Yissum is one of the top 15 technology transfer companies in the world, with over 6,100 patents and 1,750 inventions licensed over 46 years. It works to commercialize research from The Hebrew University of Jerusalem and affiliated hospitals. Yissum is taking a more active role in technology transfer by creating funding platforms for projects at all stages of development and securing different funding opportunities. This helps bridge the "valley of death" between academic research and commercialization. New business models under consideration include a royalty-based funding model, utilizing Yissum's holdings in spin-off companies through IPO, and establishing an incubator to jointly invest and manage multiple early-stage projects.